Literature DB >> 33308475

Retinal vascular occlusions.

Ingrid U Scott1, Peter A Campochiaro2, Nancy J Newman3, Valérie Biousse4.   

Abstract

Acute retinal vascular occlusions are common causes of visual impairment. Although both retinal artery occlusions and retinal vein occlusions are associated with increased age and cardiovascular risk factors, their pathophysiology, systemic implications, and management differ substantially. Acute management of retinal artery occlusions involves a multidisciplinary approach including neurologists with stroke expertise, whereas treatment of retinal vein occlusions is provided by ophthalmologists. Optimisation of systemic risk factors by patients' primary care providers is an important component of the management of these two disorders.
Copyright © 2020 Elsevier Ltd. All rights reserved.

Entities:  

Mesh：

Year:  2020        PMID： 33308475      PMCID： PMC9546635          DOI： 10.1016/S0140-6736(20)31559-2

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   202.731


  152 in total

1.  2011 ASA/ACCF/AHA/AANN/AANS/ACR/ASNR/CNS/SAIP/ SCAI/SIR/SNIS/SVM/SVS guideline on the management of patients with extracranial carotid and vertebral artery disease: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines, and the American Stroke Association, American Association of Neuroscience Nurses, American Association of Neurological Surgeons, American College of Radiology, American Society of Neuroradiology, Congress of Neurological Surgeons, Society of Atherosclerosis Imaging and Prevention, Society for Cardiovascular Angiography and Interventions, Society of Interventional Radiology, Society of NeuroInterventional Surgery, Society for Vascular Medicine, and Society for Vascular Surgery.

Authors:  Thomas G Brott; Jonathan L Halperin; Suhny Abbara; J Michael Bacharach; John D Barr; Ruth L Bush; Christopher U Cates; Mark A Creager; Susan B Fowler; Gary Friday; Vicki S Hertzberg; E Bruce McIff; Wesley S Moore; Peter D Panagos; Thomas S Riles; Robert H Rosenwasser; Allen J Taylor
Journal:  Vasc Med       Date:  2011-02       Impact factor: 3.239

2.  Ranibizumab for macular edema following central retinal vein occlusion: six-month primary end point results of a phase III study.

Authors:  David M Brown; Peter A Campochiaro; Rishi P Singh; Zhengrong Li; Sarah Gray; Namrata Saroj; Amy Chen Rundle; Roman G Rubio; Wendy Yee Murahashi
Journal:  Ophthalmology       Date:  2010-04-09       Impact factor: 12.079

3.  Benign retinal vasculitis. Clinical and fluorescein angiographic study.

Authors:  C D Hart; M D Sanders; S J Miller
Journal:  Br J Ophthalmol       Date:  1971-11       Impact factor: 4.638

4.  Impact of Baseline Retinal Nonperfusion and Macular Retinal Capillary Nonperfusion on Outcomes in the COPERNICUS and GALILEO Studies.

Authors:  Nicolas Feltgen; Yuichiro Ogura; Francesco Boscia; Frank G Holz; Jean-Francois Korobelnik; David M Brown; Jeffrey S Heier; Brigitte Stemper; Kay D Rittenhouse; Friedrich Asmus; Christiane Ahlers; Robert Vitti; Namrata Saroj; Paul Mitchell
Journal:  Ophthalmol Retina       Date:  2019-02-27

5.  Argon laser photocoagulation for macular edema in branch vein occlusion. The Branch Vein Occlusion Study Group.

Authors: 
Journal:  Am J Ophthalmol       Date:  1984-09-15       Impact factor: 5.258

6.  Baseline and early natural history report. The Central Vein Occlusion Study.

Authors: 
Journal:  Arch Ophthalmol       Date:  1993-08

7.  Undertreatment of Vascular Risk Factors in Patients with Monocular Ischaemic Visual Loss.

Authors:  Angeliki Zarkali; Suk Fun Cheng; Agnes Dados; Robert Simister; Arvind Chandratheva
Journal:  Cerebrovasc Dis       Date:  2018-05-17       Impact factor: 2.762

8.  Features of patients with transient monocular blindness: a multicenter retrospective study in Japan.

Authors:  Koji Tanaka; Toshiyuki Uehara; Kazumi Kimura; Yasushi Okada; Yasuhiro Hasegawa; Norio Tanahashi; Akifumi Suzuki; Shigeharu Takagi; Jyoji Nakagawara; Kazumasa Arii; Shinji Nagahiro; Kuniaki Ogasawara; Takehiko Nagao; Shinichiro Uchiyama; Masayasu Matsumoto; Koji Iihara; Kazunori Toyoda; Kazuo Minematsu
Journal:  J Stroke Cerebrovasc Dis       Date:  2013-10-19       Impact factor: 2.136

Review 9.  Central retinal vein occlusion in young adults.

Authors:  A C Fong; H Schatz
Journal:  Surv Ophthalmol       Date:  1993 May-Jun       Impact factor: 6.048

10.  Intravenous thrombolysis in acute central retinal artery occlusion - A prospective interventional case series.

Authors:  Maximilian Schultheiss; Florian Härtig; Martin S Spitzer; Nicolas Feltgen; Bernhard Spitzer; Johannes Hüsing; André Rupp; Ulf Ziemann; Karl U Bartz-Schmidt; Sven Poli
Journal:  PLoS One       Date:  2018-05-29       Impact factor: 3.240
View more
  14 in total

1.  Retinal and optic nerve magnetic resonance diffusion-weighted imaging in acute non-arteritic central retinal artery occlusion.

Authors:  Matthew Boyko; Oana Dumitrascu; Amit M Saindane; Joseph M Hoxworth; Ranliang Hu; Tanya Rath; Wesley Chan; Alexis M Flowers; Ehab Harahsheh; Parth Parikh; Omer Elshaigi; Benjamin I Meyer; Nancy J Newman; Valérie Biousse
Journal:  J Stroke Cerebrovasc Dis       Date:  2022-07-15       Impact factor: 2.677

2.  Three-Dimensional High-Resolution Temporal Bone Histopathology Identifies Areas of Vascular Vulnerability in the Inner Ear.

Authors:  Bela Büki; Antonia Mair; Jacob M Pogson; Nicholas S Andresen; Bryan K Ward
Journal:  Audiol Neurootol       Date:  2021-12-29       Impact factor: 2.213

3.  Referral Patterns of Central Retinal Artery Occlusion to an Academic Center Affiliated With a Stroke Center.

Authors:  Alexis M Flowers; Wesley Chan; Benjamin I Meyer; Beau B Bruce; Nancy J Newman; Valérie Biousse
Journal:  J Neuroophthalmol       Date:  2021-12-01       Impact factor: 4.415

Review 4.  [Nonaretritic central retinal artery occlusion as marker for the generalized vascular risk].

Authors:  Nicolas Feltgen; Jan Liman; Maximilian Schultheiss; Martin S Spitzer; Amelie Pielen; Sven Poli
Journal:  Ophthalmologe       Date:  2021-08-04       Impact factor: 1.059

Review 5.  Rho GTPases in Retinal Vascular Diseases.

Authors:  Akiyoshi Uemura; Yoko Fukushima
Journal:  Int J Mol Sci       Date:  2021-04-01       Impact factor: 5.923

6.  Peroxisome Proliferator-Activated Receptor α Activation Protects Retinal Ganglion Cells in Ischemia-Reperfusion Retinas.

Authors:  Fei Yao; Xuan Zhang; Xueyan Yao; Xiaohua Ren; Xiaobo Xia; Jian Jiang; Lexi Ding
Journal:  Front Med (Lausanne)       Date:  2021-12-23

7.  Clinical significance of subclinical atherosclerosis in retinal vein occlusion.

Authors:  Minhyung Lyu; Yonggu Lee; Byung Sik Kim; Hyun-Jin Kim; Rimkyung Hong; Yong Un Shin; Heeyoon Cho; Jeong-Hun Shin
Journal:  Sci Rep       Date:  2021-06-07       Impact factor: 4.379

Review 8.  Treatment Landscape of Macular Disorders in Indian Patients with the Advent of Razumab™ (World's First Biosimilar Ranibizumab): A Comprehensive Review.

Authors:  Shashikant Sharma; Tanishq Sharma; Somdutt Prasad; Mahesh Gopalakrishnan; Alok Chaturvedi
Journal:  Ophthalmol Ther       Date:  2021-06-21

9.  Acute Central Retinal Artery Occlusion Seen within 24 Hours at a Tertiary Institution.

Authors:  Wesley Chan; Alexis M Flowers; Benjamin I Meyer; Beau B Bruce; Nancy J Newman; Valérie Biousse
Journal:  J Stroke Cerebrovasc Dis       Date:  2021-07-13       Impact factor: 2.677

10.  Neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR) are more prominent in retinal artery occlusion (RAO) compared to retinal vein occlusion (RVO).

Authors:  Guanghao Qin; Fang He; Hongda Zhang; Emmanuel Eric Pazo; Guangzheng Dai; Qingchi Yao; Wei He; Ling Xu; Tiezhu Lin
Journal:  PLoS One       Date:  2022-02-03       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.